This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below.

Bayer for ProfessionalsYour Resource Portal

P3 Prostate Cancer Forum: 2024

Session 4 - Looking ahead: confronting the challenges of mCRPC

P3 background - Article

In session 4, we took a deep dive into mCRPC; the latest therapies, data and key considerations for treatment sequencing in this patient group

Beyond ARIs and chemotherapy: Exploring New Horizons in mCRPC treatment – Dr Elena Castro

^▼ (radium-223 dichloride) Prescribing Information

Speakers

Dr Elena Castro
Dr Elena Castro
Consultant Medical Oncologist, Virgen de la Victoria University Hospital in Malaga, Spain

Are you interested in P3 2025?

Register your interest to attend either virtually or in-person for 2025's meeting.

Register your interest to P3 2025 now!

Register your interest in attending the P3 2025 meeting

PP-NUB-GB-1919, October 2024

P3 Prostate Cancer Forum: 2024

perspectives, possibilities, progress

PP-NUB-GB-2012, January 2025

PP-NUB-GB-2019, January 2025